Clinical Trial Update: Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating treatment for dysosmia/anosmia in pediatric patients affected by COVID-19 was terminated. Results were posted on 2024-02-08.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anosmia
• Dysosmia

Snippet

Sponsor: Amanda Stapleton | Conditions: Dysosmia, Anosmia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-02-08